normetanephrine has been researched along with Attention Deficit Disorder with Hyperactivity in 6 studies
Normetanephrine: A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.
Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Children with attention deficit disorder with hyperactivity were given either methylphenidate hydrochloride or dextroamphetamine sulfate to compare the effects on urinary excretion of catecholamines, indoleamines, and phenylethylamine (PEA)." | 3.67 | Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine. ( Brown, GL; Chuang, LW; Karoum, F; Linnoila, M; Rapoport, JL; Wyatt, RJ; Zametkin, AJ, 1985) |
| "Children with attention deficit disorder with hyperactivity were treated with methylphenidate HCl (0." | 3.67 | The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication. ( Hamburger, SD; Zametkin, AJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, AU | 1 |
| Dekirmenjian, H | 1 |
| Pliszka, SR | 1 |
| Maas, JW | 1 |
| Javors, MA | 1 |
| Rogeness, GA | 1 |
| Baker, J | 1 |
| Elia, J | 1 |
| Borcherding, BG | 1 |
| Potter, WZ | 1 |
| Mefford, IN | 1 |
| Rapoport, JL | 2 |
| Keysor, CS | 1 |
| Zametkin, AJ | 2 |
| Karoum, F | 1 |
| Linnoila, M | 1 |
| Brown, GL | 1 |
| Chuang, LW | 1 |
| Wyatt, RJ | 1 |
| Hamburger, SD | 1 |
| Wender, PH | 1 |
| Epstein, RS | 1 |
| Kopin, IJ | 1 |
| Gordon, EK | 1 |
1 trial available for normetanephrine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Stimulant drug treatment of hyperactivity: biochemical correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetam | 1990 |
5 other studies available for normetanephrine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Creatinine; Epinephrine; Glycols; Humans; Male | 1981 |
Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety.
Topics: Anxiety Disorders; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Epinephrine; Femal | 1994 |
Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child | 1985 |
The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child | 1988 |
Urinary monoamine metabolites in children with minimal brain dysfunction.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chro | 1971 |